netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.04.01  Expand sub section  Drugs for urinary retention
07.04.01  Expand sub section  Alpha-blockers
Doxazosin
View adult BNF View SPC online View childrens BNF
Formulary
Green

Tablets 1mg, 2mg, 4mg

 
Link  UKMI Q&A: How should conversion between doxazosin formulations be carried out?
Link  UKMI Q&A: What is the evidence comparing doxazosin XL with standard doxazosin?
   
Prazosin
View adult BNF View SPC online View childrens BNF
Formulary
Green

Tablets 500 micrograms, 1mg, 2mg

 
   
Tamsulosin
View adult BNF View SPC online View childrens BNF
Formulary

Modified release capsules 400 micrograms

 

Note: Unlicensed use approved for treatment of ureteric colic.

 
   
07.04.01  Expand sub section  Parasympathomimetics
 ....
 Non Formulary Items
Alfuzosin  (Xatral®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Dutasteride and Tamsulosin  (Combodart®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Indoramin  (Doralese®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Terazosin

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Routine prescribing within licensed indication  

Amber 1

Specialist recommendation followed by GP initiation and continuation  

Amber 2

Specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation   

Amber 3

Specialist initiation and stabilisation followed by GP continuation  

Amber SCG

Specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline  

Red

Hospital or specialist prescribing only  

Red Red

These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.  

netFormulary